{"schema_version":"secwatch.filing_event.v1","accession":"0001640334-23-001812","form_type":"8-K","ticker":"LEXX","cik":"0001348362","company_name":"Lexaria Bioscience Corp.","filed_at":"2023-10-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:28.721902+00:00","generated_at":"2026-06-10T00:35:07.957702+00:00","sec_items":["5.07","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Lexaria shareholders approve reverse stock split; company granted two Canadian patents","bullets":["Shareholders approved reverse stock split with ratio between 2:1 and 12:1 (67% for).","Entered 3-month investor relations contract with Andrew Barwicki Inc. for $99,500.","Granted Canadian patent for DehydraTECH in ready-to-drink beverages (expires Dec 2036).","Granted Canadian patent for tobacco leaves infused with lipophilic agents (expires Sep 2039).","Total granted patents now 37 worldwide."],"urls":{"canonical":"https://secwatch.observer/filing/0001640334-23-001812","json":"https://secwatch.observer/filing/0001640334-23-001812.json","markdown":"https://secwatch.observer/filing/0001640334-23-001812.md","text":"https://secwatch.observer/filing/0001640334-23-001812.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1348362/000164033423001812/0001640334-23-001812-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1348362/000164033423001812/lxrp_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T00:35:07.957702+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"2b6ad52aa19812ca9b8d90e5f3dd19d07ec5d580","claim":"Lexaria Bioscience Corp. shareholders approved To approve a reverse stock split with such ratio to be not less than 2 current shares for one post reverse stock split share and no more than 12 current shares for one post reverse stock split. at the 2023-10-10 meeting.","evidence_excerpt":"Matter Being Voted On For Against/ Withheld Abstain Broker Non-Vote Percent Approved By 1 To Approve a Reverse Stock Split with such ratio to be not less than 2 current shares for one post reverse stock split share and no more than 12 current shares for one post reverse stock split. 3,120,754 1,546,507 13,453 0 67 %","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1348362/000164033423001812/0001640334-23-001812-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"reverse split"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-10-10"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}